Castle Biosciences, Inc.CSTLNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank50
5Y CAGR-49.3%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
-49.3%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20258.91%
202417.18%
20231.34%
2022-3.30%
20215.29%
2020266.88%
2019434.46%
2018128.15%
20170.00%